Publication:
Analysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC

Simple item page
dc.contributor.coauthorMiethke, Alexander
dc.contributor.coauthorMoukarzel, Adib
dc.contributor.coauthorPorta, Gilda
dc.contributor.coauthorEsquer, Joshue Covarrubias
dc.contributor.coauthorCzubkowski, Piotr
dc.contributor.coauthorOrdonez, Felipe
dc.contributor.coauthorCandusso, Manila
dc.contributor.coauthorAqul, Amal A.
dc.contributor.coauthorSquires, Robert H.
dc.contributor.coauthorSokal, Etienne
dc.contributor.coauthorD'Agostino, Daniel
dc.contributor.coauthorBaumann, Ulrich
dc.contributor.coauthorD'Antiga, Lorenzo
dc.contributor.coauthorKasi, Nagraj
dc.contributor.coauthorLaborde, Nolwenn
dc.contributor.coauthorLin, Chuan-Hao
dc.contributor.coauthorGilmour, Susan
dc.contributor.coauthorMittal, Naveen
dc.contributor.coauthorChiou, Fang Kuan
dc.contributor.coauthorHorslen, Simon P.
dc.contributor.coauthorHuber, Wolf-Dietrich
dc.contributor.coauthorDavid-Feliciano, Susan
dc.contributor.coauthorChien, Elaine
dc.contributor.coauthorMogul, Douglas
dc.contributor.coauthorGarner, Will
dc.contributor.coauthorNunes, Tiago
dc.contributor.coauthorLascau, Anamaria
dc.contributor.coauthorVig, Pamela
dc.contributor.coauthorHupertz, Vera
dc.contributor.coauthorGonzalez-Peralta, Regino
dc.contributor.coauthorEkong, Udeme
dc.contributor.coauthorHartley, Jane
dc.contributor.coauthorLaverdure, Noemie
dc.contributor.coauthorOvchinsky, Nadia
dc.contributor.coauthorThompson, Richard
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorArıkan, Çiğdem
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:38:31Z
dc.date.issued2023
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessN/A
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.doi10.1016/S0168-8278(23)01039-5
dc.identifier.eissn1600-0641
dc.identifier.embargoN/A
dc.identifier.issn0168-8278
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22691
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(23)01039-5
dc.identifier.volume78
dc.identifier.wos001037135101161
dc.keywordsProgressive familial intrahepatic cholestasis
dc.keywordsTreatment-emergent adverse events
dc.keywordsMaralixibat
dc.keywordsSerum bile acids
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of Hepatology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleAnalysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorArıkan, Çiğdem
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext